Substance / Medication

Dutasteride

Overview

Active Ingredient
dutasteride
RxNorm CUI
228790
Labeler: AvKAREUpdated: 2026-01-13T00:00:00.000ZFull label on DailyMed

Contraindications

When this intervention should not be used

Dutasteride and tamsulosin hydrochloride capsules are contraindicated for use in: [see 5.6 8.1 Warnings and Precautions (), Use in Specific Populations () ] Pregnancy. Dutasteride use is contraindicated in females who are pregnant. In animal reproduction and developmental toxicity studies, dutasteri

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Effectiveness and Safety of Intralesional Dutasteride in Patients With Androgenic Alopecia: A Systematic Review and Meta-Analysis.
Almeziny Abdullah, Alghamdi Asail, Alajlan Alhanoof et al. · J Cosmet Dermatol · 2025
PMID: 41367323Meta-AnalysisFull text (PMC)
Dutasteride in the treatment of frontal fibrosing alopecia: Systematic review and meta-analysis.
Seo Hyun-Min, Oh Se Uk, Kim Sungyu et al. · J Eur Acad Dermatol Venereol · 2024
PMID: 38357767Meta-Analysis
Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
Lee Solam, Lee Young Bin, Choe Sung Jay et al. · Acta Derm Venereol · 2019
PMID: 30206635Meta-Analysis
Dutasteride on benign prostatic hyperplasia: a meta-analysis on randomized clinical trials in 6460 patients.
Wu Xiao-Jun, Zhi Yi, Zheng Ji et al. · Urology · 2014
PMID: 24246318Meta-Analysis
Systematic review evaluating cardiovascular events of the 5-alpha reductase inhibitor - Dutasteride.
Loke Y K, Ho R, Smith M et al. · J Clin Pharm Ther · 2013
PMID: 23815285Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Dutasteride (substance)
SNOMED CT
385572003
UMLS CUI
C0754659
RxNorm CUI
228790
Labeler
AvKARE

Clinical Data

This intervention maps to 6 entities in the Healos knowledge graph.

2
Conditions
1
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.